Clinical Trials
2 trialsNCT04507919 2024-11-12
Managed Access Program Cohort Treatment Plan CTMT212X2002I to Provide Access to Trametinib and Dabrafenib Combination Therapy for Patients With BRAF V600 Mutation-positive Advanced Non-Small Cell Lung Cancer
Novartis
No longer available
NCT03503890 2019-09-10
Expanded Access to Rovalpituzumab Tesirine
AbbVie
No longer available